Cardiac resynchronization therapy prognosis: Difference between revisions

Jump to navigation Jump to search
Kristin Feeney (talk | contribs)
New page: {{Cardiac resynchronization therapy}} {{CMG}}; {{AOEIC}}: Bhaskar Purushottam, M.D. [mailto:bpurushottam@gmail.com] '''''Synonyms and Keywords:''''' CRT ==Overview== ==Non-responders== 3...
 
WikiBot (talk | contribs)
 
(6 intermediate revisions by 3 users not shown)
Line 1: Line 1:
__NOTOC__
{{Cardiac resynchronization therapy}}
{{Cardiac resynchronization therapy}}
{{CMG}}; {{AOEIC}}: Bhaskar Purushottam, M.D. [mailto:bpurushottam@gmail.com]
{{CMG}}; {{AOEIC}}: Bhaskar Purushottam, M.D. [mailto:bpurushottam@gmail.com]
'''''Synonyms and Keywords:''''' CRT


==Overview==
==Overview==
Approximately 30% of patients undergoing CRT will not sustain clinical or functional improvements for a wide variety of reasons.


==Non-responders==
==Non-responders==
30% of the CRT recipients are considered non-responders. A patient is considered a non-responder if there are no significant clinical or functional improvement after CRT as measured in the landmark trials (as mentioned above under clinical benefits). There are several plausible causes to explain a non-responder. As mentioned earlier, not all patients with QRS duration greater than or equal to 0.12 seconds have mechanical dyssynchrony. Unfortunately, the PROSPECT<ref name="pmid18458170">{{cite journal| author=Chung ES, Leon AR, Tavazzi L, Sun JP, Nihoyannopoulos P, Merlino J et al.| title=Results of the Predictors of Response to CRT (PROSPECT) trial. | journal=Circulation | year= 2008 | volume= 117 | issue= 20 | pages= 2608-16 | pmid=18458170 | doi=10.1161/CIRCULATIONAHA.107.743120 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=18458170  }} </ref> trial which set out to examine the various echocardiographic parameters to predict CRT response was not successful. Some of the major limitations in the study were the technical difficulties in obtaining the dyssynchrony parameters and the discrepancies among the different centers. The other reasons could be lead placement in regions of the left ventricle which is not dyssynchronous or fibrosis with no live myocardium. In fact, anterior left ventricular lead placement has been associated with worsening hemodynamics. Also, lack of sufficient biventricular pacing could result in a non-responder secondary to high left ventricular capture thresholds, lead dislodgement, a long atrioventricular delay, atrial tachyarrhythmias with rapid ventricular response and frequent premature ventricular contractions. Lack of optimal atrioventricular and ventricular to ventricular (i.e., right ventricle to left ventricle) timing can result in a non-responder.
30% of the CRT recipients are considered "non-responders". A patient is considered a "non-responder" if there is no significant clinical or functional improvement following CRT. There are multiple explanations as to why some patients are non-responders.
 
#Not all patients with QRS duration greater than or equal to 0.12 seconds have mechanical dyssynchrony. Unfortunately, the PROSPECT<ref name="pmid18458170">{{cite journal| author=Chung ES, Leon AR, Tavazzi L, Sun JP, Nihoyannopoulos P, Merlino J et al.| title=Results of the Predictors of Response to CRT (PROSPECT) trial. | journal=Circulation | year= 2008 | volume= 117 | issue= 20 | pages= 2608-16 | pmid=18458170 | doi=10.1161/CIRCULATIONAHA.107.743120 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=18458170  }} </ref> trial which set out to examine the various echocardiographic parameters to predict CRT response was not successful. Some of the major limitations in the study were the technical difficulties in obtaining the dyssynchrony parameters and the discrepancies among the different centers.
==Unmet Needs==
#The leads may have been placed in regions of the left ventricle which are not dyssynchronous
The following are remaining unmet needs:
#The leads may have been placed in regions with fibrosis or viable myocardium.
*The identification of patients who would definitely benefit from CRT (i.e. reducing the number of non-responders). Different imaging modalities and dyssynchrony parameters may accurately reveal mechanical dyssynchrony and therefore predict a CRT responder, especially in patients with a narrow [[QRS complex]].
#Anterior left ventricular lead placement has been associated with worsening hemodynamics.
*Further confirmatory evidence regarding the benefit of atrioventricular ablation versus pharmacological rate control in optimizing the clinical benefits is needed. In addition to atrioventricular and Ventricular-Ventricular optimization, other device based changes need to be explored so as to reap the complete benefits of CRT.
#Non-responsiveness can occur due to high left ventricular capture thresholds
#Lead dislodgement
#Long [[atrioventricular delay]]
#Atrial tachyarrhythmias with rapid ventricular response
#Frequent [[premature ventricular contraction]]s.
#Lack of optimal atrioventricular and ventricular to ventricular (i.e., right ventricle to left ventricle) timing can result in non-responsiveness.


==References==
==References==
Line 18: Line 24:
{{WH}}
{{WH}}
{{WS}}
{{WS}}
[[CME Category::Cardiology]]
[[Category:Cardiology]]

Latest revision as of 07:23, 15 March 2016

Cardiac resynchronization therapy Microchapters

Home

Overview

Indications

Landmark Trials

Contraindications

Pathophysiologic Basis for CRT

Treatment

Preoperative Evaluation

Procedure

Recovery

Outcomes and Prognosis

Complications

Cardiac resynchronization therapy prognosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Cardiac resynchronization therapy prognosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Cardiac resynchronization therapy prognosis

CDC on Cardiac resynchronization therapy prognosis

Cardiac resynchronization therapy prognosis in the news

Blogs on Cardiac resynchronization therapy prognosis

Directions to Hospitals Administering Cardiac resynchronization therapy

Risk calculators and risk factors for Cardiac resynchronization therapy prognosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief:: Bhaskar Purushottam, M.D. [2]

Overview

Approximately 30% of patients undergoing CRT will not sustain clinical or functional improvements for a wide variety of reasons.

Non-responders

30% of the CRT recipients are considered "non-responders". A patient is considered a "non-responder" if there is no significant clinical or functional improvement following CRT. There are multiple explanations as to why some patients are non-responders.

  1. Not all patients with QRS duration greater than or equal to 0.12 seconds have mechanical dyssynchrony. Unfortunately, the PROSPECT[1] trial which set out to examine the various echocardiographic parameters to predict CRT response was not successful. Some of the major limitations in the study were the technical difficulties in obtaining the dyssynchrony parameters and the discrepancies among the different centers.
  2. The leads may have been placed in regions of the left ventricle which are not dyssynchronous
  3. The leads may have been placed in regions with fibrosis or viable myocardium.
  4. Anterior left ventricular lead placement has been associated with worsening hemodynamics.
  5. Non-responsiveness can occur due to high left ventricular capture thresholds
  6. Lead dislodgement
  7. Long atrioventricular delay
  8. Atrial tachyarrhythmias with rapid ventricular response
  9. Frequent premature ventricular contractions.
  10. Lack of optimal atrioventricular and ventricular to ventricular (i.e., right ventricle to left ventricle) timing can result in non-responsiveness.

References

  1. Chung ES, Leon AR, Tavazzi L, Sun JP, Nihoyannopoulos P, Merlino J; et al. (2008). "Results of the Predictors of Response to CRT (PROSPECT) trial". Circulation. 117 (20): 2608–16. doi:10.1161/CIRCULATIONAHA.107.743120. PMID 18458170.

Template:WH Template:WS CME Category::Cardiology